160 related articles for article (PubMed ID: 31376467)
41. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
42. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
43. Optimizing photodynamic therapy by liposomal formulation of the photosensitizer pyropheophorbide-a methyl ester: in vitro and ex vivo comparative biophysical investigations in a colon carcinoma cell line.
Guelluy PH; Fontaine-Aupart MP; Grammenos A; Lécart S; Piette J; Hoebeke M
Photochem Photobiol Sci; 2010 Sep; 9(9):1252-60. PubMed ID: 20714673
[TBL] [Abstract][Full Text] [Related]
44. Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies.
Pucelik B; Paczyński R; Dubin G; Pereira MM; Arnaut LG; Dąbrowski JM
PLoS One; 2017; 12(10):e0185984. PubMed ID: 29016698
[TBL] [Abstract][Full Text] [Related]
45. Inclusion complex vs. conjugation of hydrophobic photosensitizers with β-cyclodextrin: Improved disaggregation and photodynamic therapy efficacy against glioblastoma cells.
Ben Mihoub A; Youssef Z; Colombeau L; Jouan-Hureaux V; Arnoux P; Frochot C; Vanderesse R; Acherar S
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110604. PubMed ID: 32228929
[TBL] [Abstract][Full Text] [Related]
46. Self-assembled porphyrin-peptide cages for photodynamic therapy.
Ghosh C; Ali LMA; Bessin Y; Clément S; Richeter S; Bettache N; Ulrich S
Org Biomol Chem; 2024 Feb; 22(7):1484-1494. PubMed ID: 38289387
[TBL] [Abstract][Full Text] [Related]
47. Dual-targeting nanosystem for enhancing photodynamic therapy efficiency.
Xu J; Zeng F; Wu H; Yu C; Wu S
ACS Appl Mater Interfaces; 2015 May; 7(17):9287-96. PubMed ID: 25876183
[TBL] [Abstract][Full Text] [Related]
48. New porphyrin amino acid conjugates: synthesis and photodynamic effect in human epithelial cells.
Serra VV; Zamarrón A; Faustino MA; Cruz MC; Blázquez A; Rodrigues JM; Neves MG; Cavaleiro JA; Juarranz A; Sanz-Rodríguez F
Bioorg Med Chem; 2010 Aug; 18(16):6170-8. PubMed ID: 20638288
[TBL] [Abstract][Full Text] [Related]
49. Photodynamic Therapy Mediated by a Novel Chlorin Derivative, TONS 501-Na, in EMT6 cells.
Osaki T; Sakata I; Uto Y; Azuma K; Murahata Y; Tsuka T; Itoh N; Imagawa T; Okamoto Y
Anticancer Res; 2017 Apr; 37(4):1723-1728. PubMed ID: 28373434
[TBL] [Abstract][Full Text] [Related]
50. Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer.
Zhang GD; Harada A; Nishiyama N; Jiang DL; Koyama H; Aida T; Kataoka K
J Control Release; 2003 Dec; 93(2):141-50. PubMed ID: 14636720
[TBL] [Abstract][Full Text] [Related]
51. Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.
Berg K; Nordstrand S; Selbo PK; Tran DT; Angell-Petersen E; Høgset A
Photochem Photobiol Sci; 2011 Oct; 10(10):1637-51. PubMed ID: 21773635
[TBL] [Abstract][Full Text] [Related]
52. Current status of liposomal porphyrinoid photosensitizers.
Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, characterisation and in vitro investigation of photodynamic activity of 5-(4-octadecanamidophenyl)-10,15,20-tris(N-methylpyridinium-3-yl)porphyrin trichloride on HeLa cells using low light fluence rate.
Malatesti N; Harej A; Kraljević Pavelić S; Lončarić M; Zorc H; Wittine K; Andjelkovic U; Josic D
Photodiagnosis Photodyn Ther; 2016 Sep; 15():115-26. PubMed ID: 27431589
[TBL] [Abstract][Full Text] [Related]
54. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
55. Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo.
Zhang LJ; Zhang XH; Liao PY; Sun JJ; Wang L; Yan YJ; Chen ZL
J Photochem Photobiol B; 2016 Oct; 163():224-31. PubMed ID: 27591565
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and Aggregation of a Porphyrin-Cored Hyperbranched Polyglycidol and Its Application as a Macromolecular Photosensitizer for Photodynamic Therapy.
Kadhim A; McKenzie LK; Bryant HE; Twyman LJ
Mol Pharm; 2019 Mar; 16(3):1132-1139. PubMed ID: 30694688
[TBL] [Abstract][Full Text] [Related]
57. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization.
Renno RZ; Miller JW
Adv Drug Deliv Rev; 2001 Oct; 52(1):63-78. PubMed ID: 11672876
[TBL] [Abstract][Full Text] [Related]
58. Enhanced photodynamic efficiency achieved via a dual-targeted strategy based on photosensitizer/micelle structure.
Xu J; Zeng F; Wu H; Hu C; Wu S
Biomacromolecules; 2014 Nov; 15(11):4249-59. PubMed ID: 25329523
[TBL] [Abstract][Full Text] [Related]
59. Singlet oxygen-responsive micelles for enhanced photodynamic therapy.
Li X; Gao M; Xin K; Zhang L; Ding D; Kong D; Wang Z; Shi Y; Kiessling F; Lammers T; Cheng J; Zhao Y
J Control Release; 2017 Aug; 260():12-21. PubMed ID: 28527734
[TBL] [Abstract][Full Text] [Related]
60. Cationic dendritic starch as a vehicle for photodynamic therapy and siRNA co-delivery.
Engelberth SA; Hempel N; Bergkvist M
J Photochem Photobiol B; 2017 Mar; 168():185-192. PubMed ID: 28237436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
